Clinical Trials Logo
  1. Home
  2. Eye Disease
  3. NCT02321176

Pharmacokinetics of Trans-resveratrol Based Nutritional Supplement and Its Three Metabolites in Human Eyes and Blood

Eye Disease Clinical Trial

Official title:
Pharmacokinetics of Trans-resveratrol Based Nutritional Supplement and Its Three Metabolites in Human Eyes and Blood

Clinical Trial Summary

There is blood-eye barrier in eyes,but some oral medicines can enter in the tissues of eyes.

The primary objective of the study is to study the Pharmacokinetics of Trans-resveratrol and Its three Metabolites in Human Eyes and Blood

Clinical Trial Description

This was a single-blind, randomised study investigating single oral dose of LONGEVINEX in two groups of about 20 Patients with rhegmatogenous retinal detachment retinal detachment（males and females).The subjects received 100mg LONGEVINEX everyday,a total of three days before surgery. ;

Study Design

Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject)

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02321176
Study type Interventional
Source Huazhong University of Science and Technology
Contact Wang Shuaishuai
Phone 15623422892
Email 949990624@qq.com
Status Recruiting
Phase N/A
Start date March 2014
Completion date April 2015
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02500862 - Characterization of Potential Biomarkers of Eye Disease and Vision
Completed NCT02003547 - A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects Phase 1
Completed NCT01693315 - Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma Phase 2
Recruiting NCT02321189 - The Effect of Resveratrol Based Nutritional Supplement on Choroidal Thickness N/A
Completed NCT00073099 - Digital Photography to Evaluate Dry Eye N/A
Completed NCT00678860 - Validation of Computerized Vision-Targeted Quality-of-Life Questionnaires N/A
Completed NCT00957190 - The DIOXXACT Trial(Diurnal IOP and OBF Xalatan vs Xalatan And Cosopt Trial) Phase 4
Active, not recruiting NCT00386906 - Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma Phase 1
Completed NCT00001737 - Cyclosporin Implant to Treat Uveitis Phase 1
Completed NCT04912622 - RPE Characterisation With Transscleral Optical Phase Imaging in Retinal Disorders N/A
Completed NCT00591110 - Project inCharge: Increasing the Rate of Comprehensive Eye Care Utilization by Older African Americans Through Community-Based Eye Health Education Program N/A
Unknown status NCT00649766 - Tailored Messages to Increase Eye Examination Behavior N/A
Completed NCT02851251 - Multicenter Neonatal Eye Disease Screening in China
Active, not recruiting NCT01648452 - CNTF Implants for CNGB3 Achromatopsia Phase 1/Phase 2
Enrolling by invitation NCT01396967 - Trying a New Device for Performing Capsulorhexis in Cataract Surgery Surgery Phase 1
Completed NCT00270647 - Physicians' Health Study II N/A
Completed NCT00001224 - Analysis of Eye Tissue N/A
Completed NCT00473278 - Analysis of Human Tear Proteins in Children N/A
Terminated NCT00453258 - Pilot Study of Human Tear Proteins N/A
Recruiting NCT02821767 - Natural History, Pathogenesis, and Outcome of Ocular Disorders